Stock-outs & silver linings - The Hindu BusinessLine
Serum Institute becomes 7th Indian partner to manufacture Russia's Sputnik V vaccine - BusinessToday
Plus efficace que le vaccin : injecter le vrai virus... « ralenti »
Serum Institute claims COVID-19 vaccine to be market ready by 2022 - BusinessToday
Codagenix uses synthetic biology and ML in vaccine development
Codagenix uses synthetic biology and ML in vaccine development
Codagenix and Serum Institute of India Announce Commencement of First-in-Human Trial of COVI-VAC, A Single Dose, Intranasal Live Attenuated Vaccine for COVID-19
Codagenix uses synthetic biology and ML in vaccine development
A new approach to a Covid-19 nasal vaccine shows early promise | CNN
codagenix: Latest News & Videos, Photos about codagenix | The Economic Times - Page 1
Keri Wyllie - Associate Director, Translational Biology - Codagenix Inc. | LinkedIn
Codagenix Company Profile: Valuation & Investors | PitchBook
Codagenix Announces Close of $25 million Extension of Series B
Codagenix Inc. on LinkedIn: We would like to highlight the incredible work of our CSO, Dr. Steffen…
Long Island biotech lands $25M funding from Indian partner, others - Newsday
Home | Codagenix
The pandemic pipeline
Coronavirus: Both a threat and opportunity for India
Inside India's Vaccine Ecosystem - BusinessToday - Issue Date: Dec 13, 2020
Wall Street Snaps up Drug Companies Offering Hopes of Coronavirus Drug
Codagenix and Serum Institute of India Announce Commencement of First-in-Human Trial of COVI-VAC, A Single Dose, Intranasal Live Attenuated Vaccine for COVID-19
Codagenix raises $20 million for a new flu vaccine and other therapies | TechCrunch
Getting a Nose for Vaccines
